Month: December 2014

When is a little treatment too much treatment? That curiosity was the foundation of a new study out of McGill University Health Center in Montreal.[i] The research team followed 157 patients who had been diagnosed with unilateral prostate cancer (cancer on one side of the gland only) and followed by repeat biopsy for a median keep reading

As the song goes, “The hip bone is connected to the thigh bone…” but it fails to mention a unique relationship between the liver and the prostate. Although they are very different in their composition and function, they are indirectly connected by a blood-circulated fat, and a drug used to control its levels. The fat keep reading

At this year’s American Urological Association annual meeting in Orlando, FL, there were numerous courses that offer continuing education credits for physicians. One of the courses was directed by Dr. J. Stephen Jones who, for five years, served as Chair of the Urology Department at the Cleveland Clinic. He is very well respected in the keep reading

Here is my favorite definition of medicine: the science and art dealing with the maintenance of health and the prevention, alleviation, or cure of disease. I like that it includes both science, which strives for repeatable data and results, and art, which is less tangible or predictable but which adds “soul” to science. While we keep reading

Beyond doubt, the interest in Active Surveillance for prostate cancer (AS, also called Expectant Management) is on the rise. A number of converging factors are driving the increase: Better early detection and diagnosis of low-risk disease Emerging science on which cell lines are unlikely to progress into lethal disease Broader awareness of the risks of keep reading